Lifevantage Corp (LFVN)
14.19
+0.45
(+3.28%)
USD |
NASDAQ |
Nov 13, 16:00
14.15
-0.04
(-0.28%)
After-Hours: 20:00
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 177.23M |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | 146.5% |
Valuation | |
PE Ratio | 44.22 |
PE Ratio (Forward) | Upgrade |
PS Ratio | 0.9264 |
Price to Book Value | 6.399 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | 0.04 |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 0.00 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 81.52% |
Profile
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands. |
URL | https://www.lifevantage.com |
Investor Relations URL | http://investor.lifevantage.com/ |
HQ State/Province | Utah |
Sector | Consumer Staples |
Industry | Personal Care Products |
Equity Style | Small Cap/Blend |
Next Earnings Release | Jan. 30, 2025 (est.) |
Last Earnings Release | Oct. 29, 2024 |
Next Ex-Dividend Date | Dec. 02, 2024 |
Last Ex-Dividend Date | Sep. 09, 2024 |
Ratings
Profile
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands. |
URL | https://www.lifevantage.com |
Investor Relations URL | http://investor.lifevantage.com/ |
HQ State/Province | Utah |
Sector | Consumer Staples |
Industry | Personal Care Products |
Equity Style | Small Cap/Blend |
Next Earnings Release | Jan. 30, 2025 (est.) |
Last Earnings Release | Oct. 29, 2024 |
Next Ex-Dividend Date | Dec. 02, 2024 |
Last Ex-Dividend Date | Sep. 09, 2024 |